ADXN
Price
$7.59
Change
-$0.01 (-0.13%)
Updated
Apr 24, 10:30 AM (EDT)
Capitalization
7.91M
KALV
Price
$12.69
Change
+$0.24 (+1.93%)
Updated
Apr 24, 02:35 PM (EDT)
Capitalization
611.5M
70 days until earnings call
Ad is loading...

ADXN vs KALV

Header iconADXN vs KALV Comparison
Open Charts ADXN vs KALVBanner chart's image
Addex Therapeutics
Price$7.59
Change-$0.01 (-0.13%)
VolumeN/A
Capitalization7.91M
KalVista Pharmaceuticals
Price$12.69
Change+$0.24 (+1.93%)
Volume$600
Capitalization611.5M
ADXN vs KALV Comparison Chart
Loading...
KALV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADXN vs. KALV commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADXN is a StrongBuy and KALV is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (ADXN: $7.60 vs. KALV: $12.45)
Brand notoriety: ADXN and KALV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADXN: 8% vs. KALV: 71%
Market capitalization -- ADXN: $7.91M vs. KALV: $611.5M
ADXN [@Biotechnology] is valued at $7.91M. KALV’s [@Biotechnology] market capitalization is $611.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADXN’s FA Score shows that 2 FA rating(s) are green whileKALV’s FA Score has 0 green FA rating(s).

  • ADXN’s FA Score: 2 green, 3 red.
  • KALV’s FA Score: 0 green, 5 red.
According to our system of comparison, ADXN is a better buy in the long-term than KALV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KALV’s TA Score shows that 7 TA indicator(s) are bullish.

  • KALV’s TA Score: 7 bullish, 3 bearish.

Price Growth

ADXN (@Biotechnology) experienced а +2.29% price change this week, while KALV (@Biotechnology) price change was +6.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.04%. For the same industry, the average monthly price growth was -8.89%, and the average quarterly price growth was -12.57%.

Reported Earning Dates

ADXN is expected to report earnings on Apr 30, 2024.

KALV is expected to report earnings on Jul 03, 2025.

Industries' Descriptions

@Biotechnology (+8.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KALV($612M) has a higher market cap than ADXN($7.91M). KALV YTD gains are higher at: 46.989 vs. ADXN (8.571). ADXN has higher annual earnings (EBITDA): -12.19M vs. KALV (-173.23M). KALV has more cash in the bank: 253M vs. ADXN (3.35M). ADXN has less debt than KALV: ADXN (43.8K) vs KALV (5.78M). ADXN has higher revenues than KALV: ADXN (556K) vs KALV (0).
ADXNKALVADXN / KALV
Capitalization7.91M612M1%
EBITDA-12.19M-173.23M7%
Gain YTD8.57146.98918%
P/E RatioN/AN/A-
Revenue556K0-
Total Cash3.35M253M1%
Total Debt43.8K5.78M1%
FUNDAMENTALS RATINGS
KALV: Fundamental Ratings
KALV
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
83
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KALV
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 15 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
View a ticker or compare two or three
Ad is loading...
KALV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KRUS61.292.39
+4.06%
Kura Sushi USA
RNAZ0.320.01
+1.96%
TransCode Therapeutics Inc
MAA159.521.20
+0.76%
Mid-America Apartment Communities
GPOR171.11-0.51
-0.30%
Gulfport Energy Corp
LRMR2.26-0.12
-5.04%
Larimar Therapeutics

ADXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADXN has been loosely correlated with ANVS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ADXN jumps, then ANVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADXN
1D Price
Change %
ADXN100%
-0.46%
ANVS - ADXN
41%
Loosely correlated
+2.72%
CVM - ADXN
39%
Loosely correlated
+5.20%
AGEN - ADXN
24%
Poorly correlated
-0.70%
KALV - ADXN
24%
Poorly correlated
+1.22%
SLS - ADXN
23%
Poorly correlated
+1.16%
More

KALV and

Correlation & Price change

A.I.dvisor indicates that over the last year, KALV has been loosely correlated with ATXS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if KALV jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KALV
1D Price
Change %
KALV100%
+1.22%
ATXS - KALV
46%
Loosely correlated
+12.55%
IDYA - KALV
44%
Loosely correlated
+0.91%
TRDA - KALV
43%
Loosely correlated
N/A
AVIR - KALV
43%
Loosely correlated
-0.98%
ATOS - KALV
42%
Loosely correlated
+11.25%
More